CDLX CEO Nets 7,624 Shares After RSU Vesting, Sells 6,725 for Taxes

Q: How many CDLX shares did CEO Amit Gupta acquire on July 1 2025?

14,349 common shares were acquired through RSU conversion.

Q: Why were 6,725 CDLX shares sold on July 2 2025?

The filing states the sale was solely to satisfy tax-withholding obligations from the RSU vesting event.

Q: What is Amit Gupta鈥檚 current direct ownership in Cardlytics?

After the reported transactions he holds 378,704 common shares plus 43,049 unvested RSUs.

Q: What was the weighted-average sale price of the shares disposed?

The reported weighted average price was $1.7826 per share.

Q: Does the Form 4 indicate any new compensation grants?

No. The filing covers vesting of an existing RSU award; no new grants were disclosed.

[Form 4] CoreWeave, Inc. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) 鈥� Form 4 insider activity for CEO Amit Gupta

On July 1 2025 Mr. Gupta acquired 14,349 common shares through the conversion of restricted stock units (code 鈥淢鈥�). The RSUs are part of a previously disclosed 114,796-unit award that vests in eight equal quarterly installments from July 1 2024 through April 1 2026.

On July 2 2025 he sold 6,725 shares at a weighted-average price of $1.7826 solely to cover tax-withholding obligations associated with the vesting event. No other purpose for the sale was indicated.

After the transactions Mr. Gupta directly owns 378,704 common shares and retains 43,049 unvested RSUs. Net of the tax sale, his direct equity stake increased by 7,624 shares.

The activity does not involve new option grants, cash compensation or changes to company fundamentals; it is a routine vesting-and-withholding event that modestly raises the CEO鈥檚 long-term exposure to the stock.

Positive

Net increase of 7,624 shares in CEO鈥檚 direct ownership, signalling continued alignment with shareholders.
43,049 RSUs remain outstanding, indicating further potential ownership growth as future tranches vest.

Negative

6,725 shares sold (though for tax withholding) could still be viewed as insider selling by some investors.
Transactions highlight low share price range ($1.66鈥�$1.8451), underscoring current market weakness for CDLX.

Insights

TL;DR: Routine RSU vesting; small tax sale; CEO鈥檚 net holdings rise鈥攏eutral signal, minimal market impact.

The filing reflects ordinary-course equity compensation mechanics. The 14,349-share RSU conversion expands Gupta鈥檚 direct ownership, aligning management with shareholders. The 6,725-share disposition鈥攅xplicitly for withholding鈥攔educes the optical negativity normally associated with insider selling. Post-transaction ownership of 378,704 shares plus 43,049 remaining RSUs suggests continued commitment. Given the low dollar value (~$12 k) and absence of operational disclosures, the impact on valuation or sentiment should be negligible.

07/02/2025 - 06:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Intrator Michael N

(Last)

(First)

(Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON

07039

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/30/2025		M		30,977	A	$0	7,153,663	D
Class A Common Stock	06/30/2025		M		109,380	A	$0	7,263,043	D
Class A Common Stock	06/30/2025		F		77,258⁽¹⁾	D	$159.99	7,185,785	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	06/30/2025		M			30,977	⁽³⁾	⁽⁴⁾	Class A Common Stock	30,977	$0	464,663	D
Restricted Stock Units	⁽²⁾	06/30/2025		M			109,380	⁽⁵⁾	⁽⁴⁾	Class A Common Stock	109,380	$0	1,531,260	D

Explanation of Responses:

1. Represents the number of shares of the Issuer's Class A Common Stock that have been withheld by the Issuer to satisfy income tax liabilities in connection with the net settlement of restricted stock units.

2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

3. The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

4. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

5. The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

	/s/ Kristen McVeety, as Attorney-in-Fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many CDLX shares did CEO Amit Gupta acquire on July 1 2025?

14,349 common shares were acquired through RSU conversion.

Why were 6,725 CDLX shares sold on July 2 2025?

The filing states the sale was solely to satisfy tax-withholding obligations from the RSU vesting event.

What is Amit Gupta鈥檚 current direct ownership in Cardlytics?

After the reported transactions he holds 378,704 common shares plus 43,049 unvested RSUs.

What was the weighted-average sale price of the shares disposed?

The reported weighted average price was $1.7826 per share.

Does the Form 4 indicate any new compensation grants?

No. The filing covers vesting of an existing RSU award; no new grants were disclosed.

AG真人官方

[Form 4] CoreWeave, Inc. Insider Trading Activity

Insights

FAQ

How many CDLX shares did CEO Amit Gupta acquire on July 1 2025?

Why were 6,725 CDLX shares sold on July 2 2025?

What is Amit Gupta鈥檚 current direct ownership in Cardlytics?

What was the weighted-average sale price of the shares disposed?

Does the Form 4 indicate any new compensation grants?

NASDAQ:CRWV

CRWV Rankings

CRWV Latest News

CRWV Latest SEC Filings

CRWV Stock Data

AG真人官方

Trending News

[Form 4] CoreWeave, Inc. Insider Trading Activity

Insights

Financial Analyst neutral

FAQ

How many CDLX shares did CEO Amit Gupta acquire on July 1 2025?

Why were 6,725 CDLX shares sold on July 2 2025?

What is Amit Gupta鈥檚 current direct ownership in Cardlytics?

What was the weighted-average sale price of the shares disposed?

Does the Form 4 indicate any new compensation grants?

NASDAQ:CRWV

CRWV Rankings

CRWV Latest News

CRWV Latest SEC Filings

CRWV Stock Data